Treatment Resistant Bipolar Depression

NCT00272025 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

1

Enrollment

OTHER

Sponsor class

Stopped Lundbeck withdrew committment - expiring patents and prolonged inactivity

Conditions

Bipolar Depression

Interventions

DRUG: Escitalopram
DRUG: placebo

Sponsor

Queen's University